179
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

5-Hydroxy-4-oxo-L-norvaline Depletes Intracellular Glutathione: a New Modulator of Drug Resistance

, , , , &
Pages 1953-1958 | Received 11 Jun 1999, Accepted 04 Aug 1999, Published online: 22 May 2014

  • 1) Redwood, W. R. and Colvin, M., Transport of melphalan by sensitive and resistant L1210 cells. Cancer Res., 40, 1144-1149 (1980).
  • 2) Wang, A. L. and Tew, K. D., Increased glutathione S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat. Rep., 69, 677-682 (1985).
  • 3) Pegg, A. E., Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50, 6119-6129 (1990).
  • 4) Godwin, A. K., Meister, A., O’Dwyer, P. J., Huang, C. S., Hamilton, T. C., and Anderson, A. E., High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA., 89, 3070-3074 (1992).
  • 5) Goto, S., Yoshida, K., Morikawa, T., Urata, Y., Suzuki, K., and Kondo T., Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res., 55, 4297-4301 (1995).
  • 6) Berhane, K., Widersten, M., Engstrom, A., Kozarich, J. W., and Mannervik, B., Detoxication of base propenals and other α,β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transrases. Proc. Natl. Acad. Sci. USA, 91, 1480-1484 (1994).
  • 7) Sollod, C. C., Jenns, A. E., and Daub, M. E., Cell surface redox potential as a mechanism of defense against photosensitizers in fungi. Appl. Environ. Microbiol., 58, 444-449 (1992).
  • 8) Perego, P., Weghe, J. V., Ow, D. W., and Howell, S. B., Role of determinans of cadmium sensitivity in the tolerance of Schizosaccharomyces pombe to cisplatin. Molecul. Pharmacol., 51, 12-18 (1997).
  • 9) Martinoia, E., Grill, E., Tommasini, R., Kreuz K., and Amrhein, N., ATP-dependent glutathione S-conjugate ‘export’ pump in the vacuolar membrane of plants. Nature, 364, 247-249 (1993).
  • 10) Ishikawa, T., Wright, C. D., and Ishizuka, H., GS-X pump is functionally overexpressed in cis-diamminedichloro-platinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J. Biol. Chem., 269, 29085-29093 (1994).
  • 11) Novogrodsky, A., Nehring, R. E. Jr., and Meister, A., Inhibition of amino acid transport into lymphoid cells by the glutamine analog L-2-amino-4-oxo-5-chloropentanoate. Proc. Natl. Acad. Sci. USA, 76, 4932-4935 (1979).
  • 12) Fortuniak, A., Zadzinski, R., Bilinski, T., and Bartosz, G., Glutathione depletion in the yeast Saccharomyces cerevisiae. Biochem. Molecul. Biol. Int., 38, 901-910 (1996).
  • 13) Andrews, P. A., Murphy, M. P., and Howell, S. B., Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res., 45, 6250-6253 (1985).
  • 14) Chen, Z-S., Mutoh, M., Sumizawa, T., Furukawa, T., Haraguchi, M., Tani, A., and Akiyama, S., Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells. Biochem. Biophys. Res. Commn., 236, 586-590 (1997).
  • 15) Wickner, R. B., Chromosomal and nonchromosomal mutations affecting the “killer character” of Saccharomyces cerevisiae. Genetics, 76, 423-432 (1974).
  • 16) Ohtake, Y. and Okumura, Y., Establishing a high glutathione producing yeast species. Bioscience to Industry (in Japanese), 50, 29-34 (1992).
  • 17) Disaia, P. J., Sinkovics, J. G., Rutledge, F. N., and Smith, J. P., Cell-mediated immunity to human malignant cells. Am. J. Obstet. Gynecol. 114, 979-989 (1972).
  • 18) Isonishi, S., Ochiai, K., Yasuda, M., Ohkawa, K., and Terashima, Y., Mehcanism-related circumvention of cisplatin resistance in human ovarian carcinoma cells by (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum(II) monohydrate and modulation of its sensitivity by 12-O-tetradecanoylphorbol-13-acetate. Int. J. Oncol., 5, 1309-1314 (1994).
  • 19) Kistler, M., Summer, K. H., and Eckardt, F., Isolation of glutathione-deficient mutants of the yeast Saccharomyces cerevisiae. Mutant. Res., 173, 117-120 (1986).
  • 20) Ohtake, Y., Satou, A., and Yabuuchi, Y., Isolation and Characterization of Glutathione Biosynthesis-dependent Mutans in Saccharomyces cerevisiae. Agric. Biol. Chem., 54, 3145-3150 (1990).
  • 21) Riche, J. P. Jr. and Lang, C. A., The determination of glutathione, cysteine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal. Biochem., 163, 9-15 (1987).
  • 22) Miyake, A., δ-Hydroxy-γ-oxo-L-norvaline, a new antitubercular antibiotic (2). synthetic studies. Chem. Pharm. Bull., 8, 1074-1079 (1960).
  • 23) Schmidt, U., Stabler, F., and Lieberknecht, A., Stereoselective Synthesis of the Antibiotics (+)-Negamycin and (-)-HON (RI-331). Synthesis, 482-486 (1992).
  • 24) Tatsuoka, S., Miyake, A., Hitomi, H., Ueyanagi, J., Iwasaki, H., and Yamaguchi, T., HON, a new antibiotic produced by Streptomyces Akiyoshiensis Nov. sp. J. Antibiot. Ser. A. 14, 39-43 (1961).
  • 25) Yamaguchi, H., Uchida, K., Hiratani, T., Nagate, T., Watanabe, N., and Omura, S., RI-331, a new antifungal antibiotic. Ann. N. Y. Acad. Sci., 544, 188-190 (1988).
  • 26) Yamaguchi, M., Yamaki, H., Shinoda, T., Tago, Y., Suzuki, H., Nishimura, T., and Yamaguchi, H., The mode of antifungal action of (S) 2-amino-4-oxo-5-hydroxypentanoic acid, RI-331. J. Antibiot. 43, 411-416 (1990).
  • 27) Yamaki, H., Yamaguchi, M., Imamura, H., Suzuki, H., Nishimura, T., Saito, H., and Yamaguchi, H., The mechanism of antifungal action of (S)-2-amino-4-oxo-5-hydroxypentanoic acid, RI-331: the inhibition of homoserine dehydrogenase in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun., 168, 837-843 (1990).
  • 28) O’Dwyer, P. J., Hamilton, T. C., and Young, R. C., Delection of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results. J. Natl. Cancer Inst., 84, 264-267 (1992).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.